Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 1;210 Suppl 1(Suppl 1):S136-42.
doi: 10.1093/infdis/jiu086.

Poliovirus immunity among pregnant females aged 15-44 years, Namibia, 2010

Affiliations

Poliovirus immunity among pregnant females aged 15-44 years, Namibia, 2010

Cristina V Cardemil et al. J Infect Dis. .

Abstract

Background: Poliovirus (PV) antibody seroprevalence studies assess population immunity, verify an immunization program's performance and vaccine efficacy, and guide polio eradication strategy. Namibia experienced a polio outbreak among adults in 2006, yet population seroimmunity was unknown.

Methods: We tested 2061 specimens from Namibian pregnant females aged 15-44 years for neutralizing antibody to PV types 1-3 (PV1-3); all females were sampled during the 2010 National HIV Sentinel Survey. We determined the proportion of females seropositive for PV antibody by 5-year age strata, and analyzed factors associated with seropositivity, including age, gravidity, human immunodeficiency virus (HIV) infection status, residence, and antiretroviral treatment, by log-binomial regression.

Results: The seroprevalence was 94.6% for PV1, 97.0% for PV2, and 85.1% for PV3. HIV-positive females had significantly lower seroprevalence than HIV-negative females for PV1 (91.8% vs 95.3%; P<.01) and PV3 (80.0% vs 86.1%; P<.01) but not for PV2 (96.4% vs 97.1%; P=.3). The prevalence ratio of seropositivity for HIV-positive females versus HIV-negative females was 0.95 (95% confidence interval [CI], .92-.98) for PV1, 0.99 (95% CI, .97-1.01) for PV2, and 0.92 (95% CI, .87-.96) for PV3.

Conclusions: Despite relatively high PV seroprevalence, Namibia might remain at risk for a PV outbreak, particularly in lower-seroprevalence populations, such as HIV-positive females. Namibia should continue to maintain high routine polio vaccination coverage.

Keywords: HIV; Namibia; OPV; adults; neutralizing antibody; polio; poliovirus; population immunity; pregnant women; seroprevalence.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All authors: No reported conflicts.

All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Similar articles

Cited by

References

    1. Global Polio Eradication Initiative. Data and monitoring: wild poliovirus cases. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek.aspx. Accessed 20 December 2013.
    1. Centers for Disease Control and Prevention. Outbreaks following wild poliovirus importations-Europe, Africa, and Asia, January 2009– September 2010. Morb Mortal Wkly Rep 2010; 59:1393–9. - PubMed
    1. Centers for Disease Control and Prevention. Notes from the field: poliomyelitis outbreak-republic of the Congo, September 2010–February 2011. Morb Mortal Wkly Rep 2011; 60:312–3. - PubMed
    1. Patel MK, Konde MK, Didi-Ngossaki BH, et al. An outbreakof wild poliovirus in the Republic of Congo, 2010–2011. Clin Infect Dis 2012; 55:1291–8. - PMC - PubMed
    1. 2001 Namibia Housing and Population Census. http://www.paris21.org/sites/default/files/825.pdf. Accessed 20 December 2013.

Publication types